Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105


Acute and chronic acetaminophen use and renal disease: a case-control study using pharmacy and medical claims.

Kelkar M, Cleves MA, Foster HR, Hogan WR, James LP, Martin BC.

J Manag Care Pharm. 2012 Apr;18(3):234-46.


Prescription-acquired acetaminophen use and the risk of asthma in adults: a case-control study.

Kelkar M, Cleves MA, Foster HR, Hogan WR, James LP, Martin BC.

Ann Pharmacother. 2012 Dec;46(12):1598-608. doi: 10.1345/aph.1R430. Epub 2012 Nov 20.


Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.


Prescription-acquired acetaminophen use and potential overuse patterns: 2001-2008.

Gokhale M, Martin BC.

Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):226-30. doi: 10.1002/pds.2235. Epub 2011 Sep 13.


All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.

Asche CV, Singer ME, Jhaveri M, Chung H, Miller A.

J Manag Care Pharm. 2010 Nov-Dec;16(9):703-12.


Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?

Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP.

J Manag Care Pharm. 2012 Nov-Dec;18(9):690-700.


Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.

J Manag Care Pharm. 2008 Mar;14(2):164-75.


Economic burden of atopic manifestations in patients with atopic dermatitis--analysis of administrative claims.

Suh DC, Sung J, Gause D, Raut M, Huang J, Choi IS.

J Manag Care Pharm. 2007 Nov-Dec;13(9):778-89.


Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.

Doshi JA, Cai Q, Buono JL, Spalding WM, Sarocco P, Tan H, Stephenson JJ, Carson RT.

J Manag Care Spec Pharm. 2014 Apr;20(4):382-90.


Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.

Laliberté F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, Piech CT, Lefebvre P.

J Manag Care Pharm. 2009 May;15(4):312-22.


Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.

Starner CI, Schafer JA, Heaton AH, Gleason PP.

J Manag Care Pharm. 2008 Jul-Aug;14(6):523-31.


Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study.

Ruoff GE, Rosenthal N, Jordan D, Karim R, Kamin M; Protocol CAPSS-112 Study Group.

Clin Ther. 2003 Apr;25(4):1123-41.


Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

J Manag Care Pharm. 2006 Sep;12(7):546-54.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk